Concourse Financial Group Securities’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10680 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10300 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10308 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10120 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9907 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9668 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9238 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8601 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8108 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7679 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7256 |
|